Krsnaa Diagnostics Ltd Stock Falls to 52-Week Low of Rs.581

Mar 09 2026 01:56 PM IST
share
Share Via
Krsnaa Diagnostics Ltd’s shares declined sharply to a fresh 52-week low of Rs.581 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and investor participation.
Krsnaa Diagnostics Ltd Stock Falls to 52-Week Low of Rs.581

Recent Price Movement and Market Context

On 9 Mar 2026, Krsnaa Diagnostics Ltd’s stock hit an intraday low of Rs.581, representing a decline of 4.81% on the day and a 3.72% drop in closing price. This marks the lowest price level for the stock in the past 52 weeks, down from its high of Rs.891.8. The stock has been on a downward trajectory for two consecutive sessions, losing 3.86% over this period. It notably underperformed the Healthcare Services sector by 3.35% on the same day.

The broader market environment has also been challenging. The Sensex opened sharply lower at 77,056.75, down 1,862.15 points (-2.36%), and was trading at 77,134.00 (-2.26%) during the session. The index has experienced a three-week consecutive decline, losing 6.86% in that span. Meanwhile, the INDIA VIX index reached a new 52-week high, signalling elevated market volatility. The Sensex is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some underlying longer-term support.

Technical Indicators and Moving Averages

Krsnaa Diagnostics is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad weakness across technical indicators suggests sustained selling pressure and a lack of short-term momentum. The stock’s failure to hold above these averages highlights the challenges it faces in regaining investor confidence.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Financial Performance and Profitability Trends

The company’s latest quarterly results have contributed to the subdued sentiment. Krsnaa Diagnostics reported a profit after tax (PAT) of Rs.15.25 crores in the December 2025 quarter, reflecting a decline of 27.9% compared to the previous four-quarter average. This contraction in profitability has weighed on the stock’s valuation and investor outlook.

Interest expenses have increased notably, with the latest six-month interest cost rising by 21.89% to Rs.15.98 crores. The operating profit to interest ratio for the quarter stands at a low 5.96 times, indicating tighter coverage of interest obligations by operating earnings. This metric is a key indicator of financial health and suggests increased pressure on earnings to service debt costs.

Institutional Investor Participation

Institutional investors have reduced their holdings in Krsnaa Diagnostics by 0.6% over the previous quarter, now collectively holding 18.03% of the company’s shares. This decline in institutional participation is notable given these investors’ greater capacity to analyse company fundamentals. Reduced institutional interest often signals caution or reassessment of the stock’s prospects.

Long-Term and Relative Performance

Over the past year, Krsnaa Diagnostics has delivered a total return of -19.82%, significantly underperforming the Sensex, which gained 3.77% during the same period. The stock has also lagged behind the broader BSE500 index over the last three years, one year, and three months, underscoring persistent challenges in generating shareholder value relative to the market and peers.

Balance Sheet and Valuation Metrics

Despite the recent price weakness, the company maintains a relatively low average debt-to-equity ratio of 0.09 times, indicating limited leverage on its balance sheet. Return on capital employed (ROCE) stands at 11%, which is a positive indicator of capital efficiency. The enterprise value to capital employed ratio is 2, suggesting the stock is trading at a discount compared to its peers’ historical valuations.

Profit growth over the past year has been modest, with a 6.3% increase, while the price-to-earnings-to-growth (PEG) ratio is elevated at 4.3. This higher PEG ratio reflects the market’s cautious stance on the company’s earnings growth relative to its current valuation.

Krsnaa Diagnostics Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Summary of Key Metrics

Krsnaa Diagnostics Ltd’s Mojo Score currently stands at 38.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 6 Feb 2026. The company’s market capitalisation grade is 3, reflecting its small-cap status within the Healthcare Services sector. The stock’s recent underperformance relative to sector and benchmark indices, combined with declining institutional interest and subdued profitability, have contributed to this rating adjustment.

On the day of the new 52-week low, the stock’s intraday low of Rs.581 was a 4.81% decline, with a closing day change of -3.72%. The stock’s consistent trading below all major moving averages further emphasises the current bearish trend.

Market and Sector Environment

The Healthcare Services sector has faced headwinds amid broader market volatility and risk-off sentiment. Krsnaa Diagnostics’ underperformance relative to its sector peers highlights company-specific factors impacting its share price. The Sensex’s recent three-week decline of 6.86% and the spike in volatility as indicated by the INDIA VIX reaching a 52-week high have created a challenging backdrop for stocks across sectors, including healthcare.

Conclusion

Krsnaa Diagnostics Ltd’s fall to a 52-week low of Rs.581 reflects a combination of weaker quarterly profitability, rising interest costs, reduced institutional participation, and broader market pressures. The stock’s technical indicators and relative performance metrics point to ongoing challenges in regaining momentum. While the company maintains some positive balance sheet attributes and valuation discounts, the recent financial results and market dynamics have weighed on investor sentiment, resulting in the current price levels.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Krsnaa Diagnostics Ltd is Rated Sell
Mar 14 2026 10:10 AM IST
share
Share Via
Krsnaa Diagnostics Ltd Stock Hits 52-Week Low at Rs.617.4
Mar 04 2026 12:24 PM IST
share
Share Via
Krsnaa Diagnostics Ltd is Rated Sell
Mar 03 2026 10:10 AM IST
share
Share Via
Krsnaa Diagnostics Ltd is Rated Sell by MarketsMOJO
Feb 20 2026 10:10 AM IST
share
Share Via